Elevra Lithium Ltd SEC Filings

Elevra Limited, a North American lithium producer, plans to release its June 2026 Quarterly Activities Report on 28 July 2026. The company will host an investor webcast covering the results at 9:30am AEST (7:30pm EDT on 27 July 2026), with live and archived access via its website.

Elevra Lithium Limited outlines a three-stage expansion of its North American Lithium (NAL) operation and reports strong shareholder backing at the 2026 Extraordinary General Meeting. Shareholders approved resolutions to ratify a prior institutional placement of 22,540,984 shares, approve Tranche 1 convertible notes to LCSC Holdings Inc. (Canada Growth Fund), ratify shares and options issued to Lithium Offtake Inc., and approve financial assistance under section 260B of the Corporations Act, all with voting support of about 99.7% on polls.

The company presents a phased debottlenecking and capacity expansion at NAL, targeting 4,500 tonnes per day in Stage 1 by mid‑CY2027, 6,500 tonnes per day in Stage 2 by CY2028 and a full crushing circuit upgrade in CY2029. An updated scoping study indicates annual spodumene concentrate capacity increasing from 194ktpa to about 338ktpa, a rise of approximately 74%, while average life‑of‑mine C1 costs are expected to fall by around 21%. The same study shows NAL’s post‑tax 8% NPV rising from US$1,587M to US$2,305M.

To fund this growth, Elevra has arranged a strategic financing package totalling A$508M, comprising a fully underwritten A$275M equity placement, A$146M of convertible notes from Canada Growth Fund and expected net proceeds of about A$87M from the agreed sale of its Ewoyaa Project interest. The company states this package fully funds the NAL expansion under current market conditions and also supports pre‑development work at the Moblan project. The Canada Growth Fund notes, issued in two tranches, include an upfront A$65M tranche convertible at A$17.17 per share and a conditional A$81M tranche convertible at a 30% premium to a future VWAP, which Elevra highlights as helping limit dilution while aligning capital deployment with project milestones.

Elevra Lithium Limited reported a June 2026 quarter production update for its North American Lithium operation in Québec and disclosed a small equity incentive issuance. NAL produced approximately 54,479 dmt of spodumene concentrate and sold about 33,977 dmt, at an average realised provisional price of US$919 per dmt FOB. Production rose 15% from the March 2026 quarter, with May output of roughly 22,202 dmt and full‑year production of about 197,968 dmt. Inventory at quarter‑end was around 40,863 dmt, with lower realised pricing driven by contractual lagged pricing based on October 2025–March 2026 market levels. Elevra also issued 2,160 unquoted performance rights under an employee incentive scheme, bringing ordinary shares on issue to 194,016,029 and performance rights to 2,660,336.

Elevra Limited is updating investors on recent changes to its share and incentive capital reported to the ASX and furnished on a Form 6-K. The company confirms that 49,990 ELVAM performance rights lapsed on 30 June 2026 because vesting conditions were not met. Separately, 200,524 ELVAM performance rights under an employee incentive scheme converted into ELV ordinary fully paid shares between 3 March 2026 and 30 June 2026 via a transfer of existing shares. After these changes, the ASX tables show 194,016,029 ELV ordinary shares on issue and a reduced pool of unquoted ELVAM performance rights alongside existing options.

Elevra Limited has filed a Form 6-K highlighting two developments. The company has broken ground on the fully funded expansion of its North American Lithium (NAL) operation, following a May 2026 A$275 million institutional placement that funded the project and strengthened its balance sheet.

Stage 1 of the NAL Expansion is targeted for completion in mid-CY27 and is expected to lift annual spodumene concentrate production capacity by 15–20% while reducing unit operating costs through scale and efficiency improvements. The filing also reports the issue of 5,276,387 unquoted ELVAN options, exercisable at $4.80 and expiring on 31-Dec-2028, contributing to a total of 8,000,000 ELVAN options on issue alongside 194,016,029 ordinary shares.

Elevra Limited reports changes in holdings for two directors, as disclosed to the Australian Securities Exchange and furnished on this Form 6-K.

Director Laurie Lefcourt acquired 1,230 shares and now holds 9,384 shares directly. Director Lucas Dow, through indirect interests, acquired 2,460 shares under the Elevra Lithium Limited Share Purchase Plan announced on 12 May 2026, bringing his indirect holdings to 19,127 shares plus 637,892 performance rights.

Elevra Limited provides an update on its lithium operations, financial position, and growth plans across North America. Year-to-date FY26 revenue is US$167 million, with unit operating costs of US$840 per dry metric tonne and concentrate production of 143,489 dry metric tonnes, of which 147,517 tonnes were sold at a 66% recovery rate.

The company reports pro-forma net cash of US$321 million, a pro-forma market capitalization of US$1,887 million, and 193 million pro-forma shares outstanding following a strategic financing. Elevra highlights a combined lithium Ore Reserve estimate of 106Mt at 1.15% Li2O and a Mineral Resource estimate of 229Mt at 1.14% Li2O, plus an updated NAL expansion study targeting production capacity up to 338kt per year through staged mill optimization and expansion.

Elevra Lithium Limited has completed a fully underwritten institutional placement raising approximately A$275 million through issuing about 22.5 million new fully paid ordinary shares at A$12.20 per share to eligible institutional investors. The new shares represent 13.3% of existing shares on issue and are expected to settle on 15 May 2026, with trading on the ASX from 18 May 2026.

Elevra will also conduct a Share Purchase Plan for eligible shareholders in Australia and New Zealand to raise up to about A$20 million at the lower of the 5‑day VWAP before the SPP closing date or A$12.20 per share. Together with a recently announced strategic Convertible Notes investment, these equity raisings are expected to fully fund the NAL Brownfield Expansion project and key Moblan technical and pre‑development activities through to final investment decision while preserving liquidity.

Elevra Lithium Limited reports two major updates. First, it has bought back and terminated Moblan offtake rights previously held by a Waratah Capital vehicle, so Elevra now controls 100% of its pro‑rata offtake from its 60%-owned Moblan Lithium Project. This removes a life‑of‑mine sales commitment that sold 10% of Sayona’s Moblan share at a 5% discount to market prices, and was settled through an equity-based consideration that preserves cash.

Second, Elevra released an updated scoping study for expanding its North American Lithium (NAL) mine in Québec. The staged expansion keeps total initial capital at about C$366 million, but increases average annual 5.4% Li2O concentrate output from 194 kt to 338 kt post‑expansion, with life‑of‑mine C1 cash costs falling from C$1,076 to C$868 per tonne of concentrate. The expansion scenario generates a post‑tax net present value (8% discount rate) of C$3,112 million versus C$2,143 million for the base case and a post‑tax internal rate of return of 41.8%, with a 25‑month payback. The plan relies on existing ore reserves and staged debottlenecking to raise throughput, and remains subject to funding, permitting, and typical project execution risks.